One of the most debilitating, and heartbreaking, consequences of Alzheimer’s disease is the way it slowly robs people of their memories. Unfortunately, we don’t yet have a cure for Alzheimer’s, let alone a good understanding of exactly how this disease destroys memory skills. That’s why, in this first post in my series highlighting some of the awardees in NIH Common Fund’s High-Risk, High-Reward Research Program, I’m excited to introduce a young scientist who’s using some cool technology to tackle this formidable challenge: Christine Ann Denny.
A winner of a 2013 NIH Director’s Early Independence Awards (often called the “skip-the-postdoc” award), Denny has developed a technique to label the cells that encode individual memories in the brains of mice. That’s right: she tags the nerve cells that build these memories, the neurons, with a fluorescent molecule that glows.
The New Jersey native perfected her method while earning her Ph.D. in biological sciences at Columbia in the laboratory of Rene Hen. To date, she has created and labeled a specific memory in mice and then evaluated how the neural representation of the memory changes as the animals grow older or encounter stress.
Now, with funding to start her own lab, Denny plans to investigate what happens to memory-bearing neurons over the course of a lifetime, in normal and aged mice, and in a mouse model of Alzheimer’s disease. By combining her labeling technology with optogenetics—which uses light to activate or inhibit neural circuits in the brain—her goal is to identify new avenues for developing therapies that might halt, or even reverse, the process of Alzheimer’s disease-related memory loss.
Taking advantage of some fancy mouse genetics, she’ll begin by exploring which hippocampal subregions are altered in Alzheimer’s disease mice, and then whether she can use optogenetics to improve the neuronal activity in these subregions. She’s already discovered that she can use light to turn off the neurons that constitute a fear memory. When the memory was deactivated, the mouse became less fearful, as if it had forgotten the experience.
That’s a pretty ambitious agenda. But it’s exactly what NIH wants when we fund high-risk, high-reward research. We expect these awardees to be daring and ultra-creative with their ideas and experiments.
So, how did Denny get onto the biology fast track? Well, she says she’s always been very curious about the world around her—an attitude that led her to jump at the chance to skip eighth grade and take high school science and math classes. But her real inspiration to pursue neuroscience came a bit later. Upon arriving at Boston College as a freshman, Denny needed a job. While walking through the biology department, she noticed an ad for an undergraduate research assistant in Thomas Seyfried’s neuroscience lab. Denny was hired and, although she’d always thought she’d become a physician, once she stepped into the research lab, she was hooked.
Denny says Seyfried encouraged her to pursue a career in neuroscience, telling her that she had a gut instinct for asking interesting and important questions. She also clearly has an instinct for hard work, publishing seven scientific papers as an undergraduate! Both of these traits will serve her well as she takes on what, with our nation’s aging population, has to be one of the highest risk, highest reward research problems of our time.
High-Risk, High-Reward Research. (NIH Common Fund)
NIH Director’s Early Independence Awards. (NIH Common Fund)
Christine Ann Denny, Optogenetic Dissection of Hippocampal Circuitry Underlying Alzheimer’s Disease, Columbia University Health Sciences
NIH support: Office of the Director (Common Fund)